AccessPak for HIV PEP Expanded with Kaletra and Xpovio (100 MG Once Weekly)
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Xpovio (100 MG Once Weekly) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: selinexor
Brand name: Xpovio
Synonyms: Xpovio
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Xpovio (60 MG Once Weekly)
- AccessPak for HIV PEP Expanded with Kaletra-Xpovio (80 MG Once Weekly)
- AccessPak for HIV PEP Expanded with Kaletra-Xpovio (80 MG Twice Weekly)
- AccessPak for HIV PEP Expanded with Kaletra-Xryliderm
- AccessPak for HIV PEP Expanded with Kaletra-Xrylix
- AccessPak for HIV PEP Expanded with Kaletra-Xtampza ER
- Xpovio (100 MG Once Weekly)-AccessPak for HIV PEP Expanded with Viracept
- Xpovio (100 MG Once Weekly)-Accolate
- Xpovio (100 MG Once Weekly)-Accretropin
- Xpovio (100 MG Once Weekly)-Accucaine
- Xpovio (100 MG Once Weekly)-AccuHist Drops
- Xpovio (100 MG Once Weekly)-AccuHist PDX Drops